APPY - Venaxis Inc.

APPY valuation $15.50 million

Stock Price

0.50
Change: ↓ -0.048 (-8.7591%)
Last Update: 2015-01-30T16:17:37-05:00
Shares Outstanding: 30,990,029
Industry: Medical Diagnostics & Research

Venaxis is a Colorado-based in vitro diagnostic company focused on developing and commercializing its unique multi-biomarker diagnostic test, the APPY1 Test. 

Designed to aid in the identification of patients at low risk for acute appendicitis, the APPY1 Test is a simple, rapid blood test that may help physicians manage the large number of children and adolescents who enter hospital emergency departments with abdominal pain, suspected of acute appendicitis.  

Stock Price Data

Open: 0.54 Previous Close: 0.548
High: 0.559 Low: 0.496
Bid: 0.51 Ask: 0.5299

Bid Size: 10000 Ask Size: 4700
Raw Bid Size: 100 Raw Ask Size: 47
Trade Volume: 2410 Share Volume: 2099761
Last Trade Date: 2015-01-30 Last Trade Time: 16:15:00-05:00
Vwap: 0.511782926 EPS: -0.43

Fundamental Data

PE ratio: PB ratio: 0.595
Beta: 1.171965

52 Week High: 3.88 52 Week Low: 0.52
52 Week High Vwap: 3.4182 52 Week Low Vwap: 0.567792
52 Week High Volume: 9998599 52 Week Low Volume: 25281
52 Week Avg Volume: 368197
* Quotes delayed 15 minutes

Related Stocks

StockCompany namePrice
GENE Genetic Technologies Ltd Sponsored ADR 2.79
PKI PerkinElmer Inc. 45.71
A Agilent Technologies Inc. 37.77
BGMD BG Medicine Inc. 1.06
TMO Thermo Fisher Scientific 125.29
DGX Quest Diagnostics Inc. 71.07
CPHD CEPHEID 56.51
QGEN Qiagen N.V. 22.93
LH Laboratory Corp. of America Holdings 114.78
OXFD Oxford Immunotec Global PLC 11.76